GB

Martin Eduardo Romero

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Eduardo Romero. Retrieved from https://idiyas.com/inventor/martin-eduardo-romero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Martin Eduardo Romero: Innovator in Pharmaceutical Compositions

Introduction

Martin Eduardo Romero is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceutical compositions, particularly through his innovative work on electrospun fibers. His research focuses on improving the effectiveness of drug delivery systems.

Latest Patents

Martin Eduardo Romero holds a patent for "A Pharmaceutical Composition Comprising Electrohydrodynamically Obtained Fibres, The Composition Having Improved Residence Time On The Application Site." This invention relates to electrospun fibers that include a first and a second hydrophilic fiber-forming polymer, a bioadhesive substance, and a drug substance. The first hydrophilic polymer has a solubility in water at 37°C that is significantly greater than that of the second polymer, enhancing the bioadhesive properties of the composition.

Career Highlights

Martin is currently associated with Afyx Therapeutics A/S, where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to advancing drug delivery technologies that can improve patient outcomes.

Collaborations

Martin collaborates with Jens Munk Hansen, contributing to the development of cutting-edge pharmaceutical products. Their partnership exemplifies the importance of teamwork in the field of innovation.

Conclusion

Martin Eduardo Romero is a dedicated inventor whose work in pharmaceutical compositions is paving the way for advancements in drug delivery systems. His contributions are vital to the ongoing evolution of medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…